66 devices · GMDN 57393
This category includes antibodies designed to detect the Melan-A/MART-1 peptide in clinical specimens. These immunoglobulins are used in vitro diagnostic applications to qualitatively or quantitatively identify the presence of this melanoma-associated antigen, aiding in the diagnosis and monitoring of melanocytic lesions and malignant melanoma.
Devices in this category are regulated as in vitro diagnostic medical devices and are intended for use in laboratory settings. They are supplied as standalone reagents or as part of assay systems, and their regulatory status depends on the intended use and jurisdiction, with classification determined by applicable IVD regulations.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.